RYR2 and neoplasm: Although the authors did not report on the impact of RyR2 overexpression in a tumor model, increasing RyR2 activity may decrease Treg suppressive function and enhance DC-mediated activation of Tconvs in the tumor microenvironment, where Tregs frequently impede antitumor immunity (15).